Allegations of Waste, Fraud and Abuse in Pharmaceutical Pricing: Financial Impacts on Federal Health Programs
House Oversight and Government Reform Committee Testimony on Allegations of Waste, Fraud and Abuse in Pharmaceutical Pricing: Financial Impacts on Federal Health Programs
Feb. 9, 2007, 1:15 p.m.
Lewis Morris, Chief Counsel to the Inspector General, Office of Inspector General, U.S. Department of Health and Human Services